BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16861975)

  • 1. Intestinal low-grade tubuloglandular adenocarcinoma in inflammatory bowel disease.
    Levi GS; Harpaz N
    Am J Surg Pathol; 2006 Aug; 30(8):1022-9. PubMed ID: 16861975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-conventional dysplasia is frequently associated with low-grade tubuloglandular and mucinous adenocarcinomas in inflammatory bowel disease.
    Akarca FG; Yozu M; Alpert L; Kővári BP; Zhao L; Salomao M; Liao X; Westerhoff M; Lauwers GY; Choi WT
    Histopathology; 2023 Aug; 83(2):276-285. PubMed ID: 37055929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation.
    Cao D; Wilentz RE; Abbruzzese JL; Ho L; Maitra A
    Int J Gastrointest Cancer; 2005; 36(1):39-46. PubMed ID: 16227634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions - Single institution experience.
    Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J
    Pathol Res Pract; 2019 Apr; 215(4):730-737. PubMed ID: 30679085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease.
    Derikx LA; Kievit W; Drenth JP; de Jong DJ; Ponsioen CY; Oldenburg B; van der Meulen-de Jong AE; Dijkstra G; Grubben MJ; van Laarhoven CJ; Nagtegaal ID; Hoentjen F;
    Gastroenterology; 2014 Jan; 146(1):119-28.e1. PubMed ID: 24076060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermucinous, Goblet Cell-Deficient and Crypt Cell Dysplasias in Inflammatory Bowel Disease are Often Associated with Flat/Invisible Endoscopic Appearance and Advanced Neoplasia on Follow-Up.
    Choi WT; Salomao M; Zhao L; Alpert L; Setia N; Liao X; Drage MG; Westerhoff M; Cheng J; Lauwers GY; Ko HM
    J Crohns Colitis; 2022 Jan; 16(1):98-108. PubMed ID: 34232295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
    Navaneethan U; Jegadeesan R; Gutierrez NG; Venkatesh PG; Hammel JP; Shen B; Kiran RP
    J Crohns Colitis; 2013 Dec; 7(12):e684-91. PubMed ID: 23916526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease course and management strategy of pouch neoplasia in patients with underlying inflammatory bowel diseases.
    Wu XR; Remzi FH; Liu XL; Lian L; Stocchi L; Ashburn J; Shen B
    Inflamm Bowel Dis; 2014 Nov; 20(11):2073-82. PubMed ID: 25137416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk for colorectal neoplasia in patients with inflammatory bowel disease and mucosa indefinite for dysplasia.
    Lai KK; Horvath B; Xie H; Wu X; Lewis BL; Pai RK; Plesec T; Patil DT; Gordon IO; Wang Y; Shen B; Goldblum JR; Liu X
    Inflamm Bowel Dis; 2015 Feb; 21(2):378-84. PubMed ID: 25569733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of low and high-grade dysplasia in inflammatory bowel disease: the gastroenterologists' perspective and current practice in the United Kingdom.
    Thomas T; Nair P; Dronfield MW; Mayberry JF
    Eur J Gastroenterol Hepatol; 2005 Dec; 17(12):1317-24. PubMed ID: 16292084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
    Dorer R; Odze RD
    Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemistry in the diagnosis of dysplasia in chronic inflammatory bowel disease colorectal polyps.
    B Brahim E; Mrabet A; Jouini R; Koubaa W; B Sidhom R; Elloumi H; Chadli A
    Arab J Gastroenterol; 2016 Sep; 17(3):121-126. PubMed ID: 27567189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
    J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: a retrospective study comparing chromoendoscopy and white-light endoscopy.
    Ten Hove JR; Mooiweer E; van der Meulen de Jong AE; Dekker E; Ponsioen CY; Siersema PD; Oldenburg B
    Endoscopy; 2017 Feb; 49(2):161-168. PubMed ID: 27951611
    [No Abstract]   [Full Text] [Related]  

  • 15. DNA flow cytometric and interobserver study of crypt cell atypia in inflammatory bowel disease.
    Wen KW; Umetsu SE; Goldblum JR; Gill RM; Kim GE; Joseph NM; Rabinovitch PS; Kakar S; Lauwers GY; Choi WT
    Histopathology; 2019 Oct; 75(4):578-588. PubMed ID: 31111543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Risk of Advanced Neoplasia After Colonic Low-grade Dysplasia in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study.
    De Jong ME; Van Tilburg SB; Nissen LHC; Kievit W; Nagtegaal ID; Horjus CS; Römkens TEH; Drenth JPH; Hoentjen F; Derikx LAAP
    J Crohns Colitis; 2019 Dec; 13(12):1485-1491. PubMed ID: 31175827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokeratin 7/20 and mucin core protein expression in ulcerative colitis-associated colorectal neoplasms.
    Tatsumi N; Kushima R; Vieth M; Mukaisho K; Kakinoki R; Okabe H; Borchard F; Stolte M; Okanoue T; Hattori T
    Virchows Arch; 2006 Jun; 448(6):756-62. PubMed ID: 16609910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misclassification of dysplasia in patients with inflammatory bowel disease: consequences for progression rates to advanced neoplasia.
    van Schaik FD; ten Kate FJ; Offerhaus GJ; Schipper ME; Vleggaar FP; van der Woude CJ; Stokkers PC; de Jong DJ; Hommes DW; van Bodegraven AA; Siersema PD; Oldenburg B;
    Inflamm Bowel Dis; 2011 May; 17(5):1108-16. PubMed ID: 20824815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of CK7 and CK20 in preneoplastic and neoplastic lesions in ulcerative colitis.
    Stenling R; Lindberg J; Rutegård J; Palmqvist R
    APMIS; 2007 Nov; 115(11):1219-26. PubMed ID: 18092953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from 59 patients.
    Torres C; Antonioli D; Odze RD
    Am J Surg Pathol; 1998 Mar; 22(3):275-84. PubMed ID: 9500769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.